Elevated circulating SAA levels are consistently observed in conditions with a low-grade inflammatory component, such as in atherosclerosis, diabetes and obesity and are associated with increased risk of clinical coronary events (10, 11). This evidence concerns the gene SAA1 and obesity due to melanocortin 4 receptor deficiency.